Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04551430
Title Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

sarcoma

Therapies

Cabozantinib + Ipilimumab + Nivolumab

Cabozantinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University Medical Center Recruiting Stanford California 94305 United States Details
University of Colorado Recruiting Aurora Colorado 80045 United States Details
Washington University School of Medicine Recruiting Saint Louis Missouri 63110 United States Details
Abramson Cancer Center at Pennsylvania Hospital Recruiting Philadelphia Pennsylvania 19106 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field